Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mildvan

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
AIDS Care|September 15, 2006
Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgroundsM V Gwadz, N R Leonard, A Nakagawa, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complexD Mildvan, J Buzas, D Armstrong, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Management of opportunistic pneumonia in AIDSA S Teirstein, M J Rosen, D Mildvan, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1993
CD4 lymphocytopenia among injecting drug users in New York CityD C Des Jarlais, S R Friedman, M Marmor, et al.
Health Education Research|May 15, 2013
Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trialsN R Leonard, A Banfield, M Riedel, et al.
AIDS Research and Human Retroviruses|April 1, 1990
Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infectionT S Croxson, U Mathur-Wagh, S Handwerger, et al.
Annals of Internal Medicine|June 1, 1982
Opportunistic infections and immune deficiency in homosexual menD Mildvan, U Mathur, R W Enlow, et al.
Blood|October 1, 1989
Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reactionG D Ehrlich, J B Glaser, K LaVigne, et al.
JAMA|March 22, 1985
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDSF Barré-Sinoussi, U Mathur-Wagh, F Rey, et al.
BMJ (Clinical Research Ed.)|January 12, 1991
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudineM A Jacobson, P Bacchetti, A Kolokathis, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
AIDS Care|September 15, 2006
Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgroundsM V Gwadz, N R Leonard, A Nakagawa, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complexD Mildvan, J Buzas, D Armstrong, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Management of opportunistic pneumonia in AIDSA S Teirstein, M J Rosen, D Mildvan, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1993
CD4 lymphocytopenia among injecting drug users in New York CityD C Des Jarlais, S R Friedman, M Marmor, et al.
Health Education Research|May 15, 2013
Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trialsN R Leonard, A Banfield, M Riedel, et al.
AIDS Research and Human Retroviruses|April 1, 1990
Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infectionT S Croxson, U Mathur-Wagh, S Handwerger, et al.
Annals of Internal Medicine|June 1, 1982
Opportunistic infections and immune deficiency in homosexual menD Mildvan, U Mathur, R W Enlow, et al.
Blood|October 1, 1989
Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reactionG D Ehrlich, J B Glaser, K LaVigne, et al.
JAMA|March 22, 1985
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDSF Barré-Sinoussi, U Mathur-Wagh, F Rey, et al.
BMJ (Clinical Research Ed.)|January 12, 1991
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudineM A Jacobson, P Bacchetti, A Kolokathis, et al.
Pageof 9